Related Experiment Video
Updated: Mar 2, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.4K
Implementing Optimal Allocation in Clinical Trials with Multiple Endpoints.
Lu Wang1, Yong Chen2, Hongjian Zhu1
1Department of Biostatistics, University of Texas Health Science Center School of Public Health at Houston, 1200 Pressler St, Houston, Texas 77030, USA.
Journal of Statistical Planning and Inference
|May 23, 2017
Summary
This study introduces optimal allocation methods for complex clinical trials with multiple objectives. Response-adaptive randomization procedures are implemented to enhance trial efficiency and ethical considerations.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Medical Research Optimization
Background:
- Modern clinical trials frequently involve multiple competing objectives and endpoints.
- Ensuring both ethical conduct and efficiency in complex trials is a significant challenge.
- Unknown parameters and correlations between multiple endpoints complicate trial design.
Purpose of the Study:
- To determine optimal allocation proportions for two key optimization problems in clinical trials.
- To address challenges posed by numerous unknown parameters and correlated endpoints.
- To implement response-adaptive randomization procedures based on optimal allocations.
Main Methods:
- Derivation of optimal allocation proportions for maximizing test power with fixed sample size.
- Derivation of optimal allocation proportions for minimizing expected failures with fixed power.
- Implementation of derived optimal allocations using response-adaptive randomization.
Main Results:
- Optimal allocation proportions were obtained for maximizing power and minimizing failures.
- Response-adaptive randomization procedures were successfully implemented.
- Numerical studies confirmed the procedure's ability to achieve diverse objectives.
Conclusions:
- The theoretical results provide a foundation for response-adaptive randomization in complex trials.
- The developed methods enhance the efficiency and ethical considerations of clinical trials.
- This approach offers a robust framework for managing multiple endpoints and unknown parameters.
More Related Videos
Related Concept Videos
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
339
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
339
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
309
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
309
01:16Clinical Trials
11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.0K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
01:11Clinical Trials: Overview
5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
01:13Randomized Experiments
9.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
9.1K